These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26606057)

  • 21. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
    Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
    J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with the failure of first and second-line antiretroviral therapies therapy, a case control study in Cambodian HIV-1 infected children.
    Barennes H; Virak K; Rouet F; Buisson Y; Strobel M; Vibol U
    BMC Res Notes; 2016 Feb; 9():69. PubMed ID: 26850410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia.
    Myung P; Pugatch D; Brady MF; Many P; Harwell JI; Lurie M; Tucker J
    Am J Public Health; 2007 Jun; 97(6):974-7. PubMed ID: 17463375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.
    Lourenço L; Samji H; Nohpal A; Chau W; Colley G; Lepik K; Barrios R; Lima V; Hogg RS; Montaner J; Kesselring S; Moore DM
    HIV Med; 2015 Jul; 16(6):337-45. PubMed ID: 25721157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engaging HIV-infected patients in antiretroviral therapy services: CD4 cell count testing after HIV diagnosis from 2005 to 2009 in Yunnan and Guangxi, China.
    Zhang Y; Lu L; Li HQ; Liu W; Tang ZR; Fang H; Chen JY; Ma Y; Zhao Y; Chen RY; Zhang FJ
    Chin Med J (Engl); 2011 May; 124(10):1488-92. PubMed ID: 21740803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study.
    Jani IV; Sitoe NE; Alfai ER; Chongo PL; Quevedo JI; Rocha BM; Lehe JD; Peter TF
    Lancet; 2011 Oct; 378(9802):1572-9. PubMed ID: 21951656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.
    Thai S; Koole O; Un P; Ros S; De Munter P; Van Damme W; Jacques G; Colebunders R; Lynen L
    Trop Med Int Health; 2009 Sep; 14(9):1048-58. PubMed ID: 19573140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.
    Nsanzimana S; Remera E; Kanters S; Chan K; Forrest JI; Ford N; Condo J; Binagwaho A; Mills EJ
    Lancet Glob Health; 2015 Mar; 3(3):e169-77. PubMed ID: 25701995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective linkage from point of HIV testing to care and treatment in Tanga region, Tanzania.
    Kayabu DE; Ngocho JS; Mmbaga BT
    PLoS One; 2018; 13(8):e0201644. PubMed ID: 30114244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in nutritional, functional and immunological status of HIV-infected adults with antiretroviral therapy.
    Tafese Z; Berhan Y; Abebe H
    Ethiop Med J; 2012 Jan; 50(1):75-87. PubMed ID: 22519164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient enrolment into HIV care and treatment within 90 days of HIV diagnosis in eight Rwandan health facilities: a review of facility-based registers.
    Kayigamba FR; Bakker MI; Fikse H; Mugisha V; Asiimwe A; Schim van der Loeff MF
    PLoS One; 2012; 7(5):e36792. PubMed ID: 22606289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients who present late to HIV care and associated risk factors in Nigeria.
    Agaba PA; Meloni ST; Sule HM; Agbaji OO; Ekeh PN; Job GC; Nyango N; Ugoagwu PO; Imade GE; Idoko JA; Kanki PJ
    HIV Med; 2014 Aug; 15(7):396-405. PubMed ID: 24580742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD.
    Jeong SJ; Italiano C; Chaiwarith R; Ng OT; Vanar S; Jiamsakul A; Saphonn V; Nguyen KV; Kiertiburanakul S; Lee MP; Merati TP; Pham TT; Yunihastuti E; Ditangco R; Kumarasamy N; Zhang F; Wong W; Sim BL; Pujari S; Kantipong P; Phanuphak P; Ratanasuwan W; Oka S; Mustafa M; Durier N; Choi JY
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):255-61. PubMed ID: 26414065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
    Gezie LD
    BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania.
    Mullin S; Temu A; Kalluvya S; Grant A; Manji H
    Trop Med Int Health; 2011 Oct; 16(10):1291-6. PubMed ID: 21707880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India.
    Rajasekaran S; Jeyaseelan L; Raja K; Vijila S; Krithigaipriya KA; Kuralmozhi R
    J Postgrad Med; 2009; 55(4):261-6. PubMed ID: 20083872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term trends in HIV care entry: over 15 years of clinical experience from Poland.
    Siwak E; Horban A; Witak-Jędra M; Cielniak I; Firląg-Burkacka E; Leszczyszyn-Pynka M; Witor A; Muller K; Bociąga-Jasik M; Kalinowska-Nowak A; Gąsiorowski J; Szetela B; Jabłonowska E; Wójcik-Cichy K; Jankowska J; Lemańska M; Olczak A; Grąbczewska E; Grzeszczuk A; Rogalska-Plonska M; Suchacz M; Mikuła T; Łojewski W; Bielec D; Kocbach P; Błudzin W; Parczewski M
    HIV Med; 2019 Oct; 20(9):581-590. PubMed ID: 31250958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.
    Keruly JC; Moore RD
    Clin Infect Dis; 2007 Nov; 45(10):1369-74. PubMed ID: 17968837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.